Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(33%)
Results Posted
17%(1 trials)

Phase Distribution

Ph early_phase_1
1
11%
Ph not_applicable
5
56%
Ph phase_1
3
33%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
3(33.3%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(6)

Detailed Status

Completed6
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (11.1%)
Phase 13 (33.3%)
N/A5 (55.6%)

Trials by Status

completed667%
recruiting333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9